Showing results (541-550 of 585) with videos related to

Sort By:
Pageof 59
Analytical Chemistry|August 28, 2013
Automated digital microfluidic platform for magnetic-particle-based immunoassays with optimization by design of experimentsKihwan Choi, Alphonsus H C Ng, Ryan Fobel, et al.
Leukemia|February 7, 2013
Phase Ia/II, two-arm, open-label, dose-escalation study of oral panobinostat administered via two dosing schedules in patients with advanced hematologic malignanciesD J DeAngelo, A Spencer, K N Bhalla, et al.
Leukemia Research|January 1, 1982
Multicentre study on intensified remission induction therapy for acute myeloid leukemiaT Büchner, D Urbanitz, B Emmerich, et al.
Bone Marrow Transplantation|October 19, 2004
Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trialN Schmitz, P Ljungman, C Cordonnier, et al.
Annals of Hematology|May 25, 2004
Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemiaW K Hofmann, G Heil, C Zander, et al.
Blood|December 23, 2022
Oxidative DNA damage in reconstituting T cells is associated with relapse and inferior survival after allo-SCTF Karl, C Liang, R Böttcher-Loschinski, et al.
BMJ Open|October 14, 2016
Screening of gestational diabetes mellitus in early pregnancy by oral glucose tolerance test and glycosylated fibronectin: study protocol for an international, prospective, multicentre cohort trialE A Huhn, T Fischer, C S Göbl, et al.
Der Pathologe|August 17, 2010
[Molecular pathology of sarcomas. Update on the research group "Molecular Diagnosis of Sarcomas"]A V Rüsseler, B Brors, T Fischer, et al.
Annals of Hematology|October 6, 1998
Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy appliedT Fischer, A Neubauer, J Mohm, et al.
Leukemia|April 22, 2005
High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemiaR F Schlenk, U Germing, F Hartmann, et al.
Pageof 59